Recent cases in the European Patent Office (EPO), the UK, and United States illustrate substantive differences between these jurisdictions as they continue to develop their inventive step/nonobviousness frameworks.
Companies seeking approval from the U.S. Food and Drug Administration ("FDA") to market a new drug or biological product must submit extensive information to the FDA in support of approval.
Who doesn’t like free samples when shopping? But are the representatives providing those samples actually “selling” them so that they are exempt from overtime under the Fair Labor.
Who doesn’t like free samples when shopping? But are the representatives providing those samples actually selling them so that they are exempt from overtime under the Fair Labor Standards Act FLSA as outside salespersons?
Who doesn’t like free samples when shopping? But are the representatives providing those samples actually selling them so that they are exempt from overtime under the Fair Labor Standards Act FLSA as outside salespersons?